Prolactinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (20 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}};{{AE}} {{Anmol}} | |||
==Overview== | ==Overview== | ||
[[ | Conditions increasing the risk of [[prolactinoma]] inlude [[multiple endocrine neoplasia type 1]] ([[MEN 1]]), [[Carney complex]], [[McCune-Albright Syndrome]], familial isolated [[pituitary adenoma]], and MEN-1 like syndrome. | ||
==Risk factors== | ==Risk factors== | ||
[[Prolactinoma]] may occur as part of | *Most commonly, [[prolactinomas]] are sporadic. | ||
*Carney complex | *[[Prolactinoma]] may occur as part of:<ref name="pmid17613551">{{cite journal| author=Karhu A, Aaltonen LA| title=Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. | journal=Hum Mol Genet | year= 2007 | volume= 16 Spec No 1 | issue= | pages= R73-9 | pmid=17613551 | doi=10.1093/hmg/ddm036 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17613551 }} </ref><ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
*McCune-Albright Syndrome | **[[Multiple endocrine neoplasia type 1]] ([[MEN 1]]) | ||
*MEN like syndrome | **[[Carney complex]] | ||
**[[McCune-Albright Syndrome]] | |||
**Familial isolated [[pituitary adenoma]] | |||
**[[MEN 1|MEN-1]] like syndrome | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
| |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 23:50, 29 July 2020
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Prolactinoma risk factors |
|
Risk calculators and risk factors for Prolactinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Conditions increasing the risk of prolactinoma inlude multiple endocrine neoplasia type 1 (MEN 1), Carney complex, McCune-Albright Syndrome, familial isolated pituitary adenoma, and MEN-1 like syndrome.
Risk factors
- Most commonly, prolactinomas are sporadic.
- Prolactinoma may occur as part of:[1][2]
- Multiple endocrine neoplasia type 1 (MEN 1)
- Carney complex
- McCune-Albright Syndrome
- Familial isolated pituitary adenoma
- MEN-1 like syndrome
References
- ↑ Karhu A, Aaltonen LA (2007). "Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update". Hum Mol Genet. 16 Spec No 1: R73–9. doi:10.1093/hmg/ddm036. PMID 17613551.
- ↑ Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.